Profile
Robert Ho worked as a Senior Finance Director at DaVita, Inc. and as a Vice President-Investment Banking Division at Morgan Stanley & Co. LLC.
He also served as the Secretary, Chief Financial & Accounting Officer at Neoleukin Therapeutics, Inc. and as the Chief Financial Officer & Treasurer at Third Harmonic Bio, Inc. Mr. Ho received his undergraduate degree from the University of Notre Dame and his MBA from the University of Virginia Darden School of Business.
Former positions of Robert Ho
| Companies | Position | End |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Director of Finance/CFO | 10/11/2023 |
| NEUROGENE INC. | Director of Finance/CFO | 01/03/2022 |
| DAVITA INC. | Director of Finance/CFO | - |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Training of Robert Ho
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
DaVita, Inc.
DaVita, Inc. Medical/Nursing ServicesHealth Services Provides integrated dialysis services for patients suffering from chronic kidney failure | Health Services |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Robert Ho
















